Magle Chemoswed Holding AB (publ) (STO:MAGLE)
8.15
0.00 (0.00%)
Feb 26, 2026, 1:52 PM CET
STO:MAGLE Revenue
Magle Chemoswed Holding AB had revenue of 74.91M SEK in the quarter ending September 30, 2025, with 12.24% growth. This brings the company's revenue in the last twelve months to 300.49M, up 43.63% year-over-year. In the year 2024, Magle Chemoswed Holding AB had annual revenue of 240.57M with 40.27% growth.
Revenue (ttm)
300.49M
Revenue Growth
+43.63%
P/S Ratio
0.56
Revenue / Employee
2.09M
Employees
144
Market Cap
168.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 240.57M | 69.07M | 40.27% |
| Dec 31, 2023 | 171.50M | 23.51M | 15.89% |
| Dec 31, 2022 | 147.98M | 15.84M | 11.98% |
| Dec 31, 2021 | 132.15M | -10.19M | -7.16% |
| Dec 31, 2020 | 142.34M | 10.55M | 8.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xbrane Biopharma AB | 259.70M |
| Sprint Bioscience AB | 167.17M |
| IRLAB Therapeutics AB | 85.56M |
| Intervacc AB | 20.09M |
| NextCell Pharma AB | 11.06M |
| Simris Group AB (PUBL) | 2.30M |